These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30175189)

  • 21. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Relationship between Skeletal Maturity and the Calcifications Stages of Permanent Canines and Second Premolars.
    Oncan E; Akan S
    Turk J Orthod; 2021; 34(1):31-38. PubMed ID: 33828876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
    Inglis SK; Carucci S; Garas P; Häge A; Banaschewski T; Buitelaar JK; Dittmann RW; Falissard B; Hollis C; Kovshoff H; Liddle E; McCarthy S; Nagy P; Neubert A; Rosenthal E; Sonuga-Barke E; Wong I; Zuddas A; Coghill DC;
    BMJ Open; 2016 Apr; 6(4):e010433. PubMed ID: 27118284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Manag Care Pharm; 2007 Sep; 13(7):570-7. PubMed ID: 17874863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder.
    Li JJ; Li ZW; Wang SZ; Qi FH; Zhao L; Lv H; Li AY
    Psychopharmacology (Berl); 2011 Aug; 216(4):501-9. PubMed ID: 21416235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
    Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of pharyngeal airway in Korean adolescents according to skeletal pattern, sex, and cervical vertebral maturation: A cross-sectional CBCT study.
    Elagib T; Kyung HM; Hung BQ; Hong M
    Korean J Orthod; 2022 May; 52(5):345-353. PubMed ID: 36148641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder.
    Ramos-Quiroga JA; Bosch R; Castells X; Valero S; Nogueira M; Gómez N; Yelmo S; Ferrer M; Martínez Y; Casas M
    CNS Drugs; 2008; 22(7):603-11. PubMed ID: 18547128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of methylphenidate on stress fractures in patients' ages 10-29: a national database study.
    DeFroda SF; Quinn M; Yang DS; Daniels AH; Owens BD
    Phys Sportsmed; 2020 Nov; 48(4):412-416. PubMed ID: 32013692
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.
    Molina-Carballo A; Justicia-Martínez F; Moreno-Madrid F; Cubero-Millán I; Machado-Casas I; Moreno-García L; León J; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
    Psychopharmacology (Berl); 2014 Sep; 231(17):3635-45. PubMed ID: 24599397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder.
    Garg J; Arun P; Chavan BS
    Int J Appl Basic Med Res; 2015; 5(2):114-8. PubMed ID: 26097819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: A twelve-month follow-up study.
    Wang LJ; Huang YH; Chou WJ; Lee SY; Tsai CS; Lee MJ; Chou MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110181. PubMed ID: 33227299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.
    Benkert D; Krause KH; Wasem J; Aidelsburger P
    GMS Health Technol Assess; 2010 Sep; 6():Doc13. PubMed ID: 21289886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical vertebral maturation and dental age in coeliac patients.
    Costacurta M; Condò R; Sicuro L; Perugia C; Docimo R
    Oral Implantol (Rome); 2011 Jul; 4(3-4):11-7. PubMed ID: 23277868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
    Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
    Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
    Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
    Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.